Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
| Status: | Completed |
|---|---|
| Conditions: | Overactive Bladder |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 4/21/2016 |
| Start Date: | August 2006 |
| End Date: | May 2010 |
The purpose of this study is to assess the safety and effectiveness of botulinum toxin type
A in treating overactive bladder in spinal cord injury or multiple sclerosis patients.
A in treating overactive bladder in spinal cord injury or multiple sclerosis patients.
Inclusion Criteria:
- Urinary incontinence as a result of neurogenic overactive bladder due to spinal cord
injury or multiple sclerosis
- Inadequate response to anticholinergic medication used to treat overactive bladder
Exclusion Criteria:
- History of evidence of pelvic or urologic abnormality
- Previous or current diagnosis of bladder or prostate cancer
- Urinary tract infection at time of enrollment
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials